| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/10/2012 | CA2377602C Multi-neural net imaging apparatus and method |
| 04/10/2012 | CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator |
| 04/05/2012 | WO2012045067A2 Mammalian genes involved in infection |
| 04/05/2012 | WO2012045019A2 Brca deficiency and methods of use |
| 04/05/2012 | WO2012044987A2 Genetic modifiers of cystic fibrosis |
| 04/05/2012 | WO2012044956A1 Targeted genome amplification methods |
| 04/05/2012 | WO2012044933A2 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy |
| 04/05/2012 | WO2012044857A2 Devices and methods for sequencing nucleic acids |
| 04/05/2012 | WO2012044696A2 Prediction of clinical outcome in hematological malignancies using a self-renewal expression signature |
| 04/05/2012 | WO2012044586A1 In vivo reporter system |
| 04/05/2012 | WO2012044387A2 Methods and compositions for detection of analytes |
| 04/05/2012 | WO2012044353A2 Hiv-1 igg3 response in acute hiv-1 |
| 04/05/2012 | WO2012044265A1 Use of mirnas for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities |
| 04/05/2012 | WO2012044167A2 Methods and means for typing a sample comprising cancer cells based on oncogenic signal transduction pathways |
| 04/05/2012 | WO2012043820A1 Method and device for myocardial cell evaluation and myocardial toxicity inspection |
| 04/05/2012 | WO2012043601A1 Amadoriase variant |
| 04/05/2012 | WO2012043477A1 Linker for unimolecular fret biosensor based on principle of fluorescence resonance energy transfer |
| 04/05/2012 | WO2012043456A1 Device for isolating spirillum and isolation method |
| 04/05/2012 | WO2012043444A1 Measuring device and measuring method |
| 04/05/2012 | WO2012043183A1 Method for synthesizing target nucleic acid in feces |
| 04/05/2012 | WO2012042903A1 Reagent composition, sensor, sensor system, and sensor manufacture process |
| 04/05/2012 | WO2012042516A2 Prognostic methods, compositions and kits for prediction of acute lymphoblastic leukemia (all) relapse |
| 04/05/2012 | WO2012042399A1 Biosensor device and method |
| 04/05/2012 | WO2012042380A1 Systems and methods for improved stability of electrochemical sensors |
| 04/05/2012 | WO2012042374A2 Method of determining number or concentration of molecules |
| 04/05/2012 | WO2012042373A1 Systems and methods of discriminating between a control sample and a test fluid using capacitance |
| 04/05/2012 | WO2012042211A2 Analyte measurement method and system with error trapping |
| 04/05/2012 | WO2012042061A1 Methods for predicting the progression and treating a chronic kidney disease in a patient |
| 04/05/2012 | WO2012042053A1 Method of sequencing |
| 04/05/2012 | WO2012042052A1 Method of sequencing |
| 04/05/2012 | WO2012041824A1 Method for monitoring cathepsin s inhibition |
| 04/05/2012 | WO2012041486A1 Apparatus and method for evaluating characteristics of target molecules |
| 04/05/2012 | WO2012041332A2 Genetic variations in the interleukin-6 receptor gene as predictors of the response of patients to treatment with interleukin-6 receptor inhibitors |
| 04/05/2012 | WO2012040996A1 Primers and method for detection and identification of esophageal hpv virus |
| 04/05/2012 | WO2012040784A1 Gene marker sets and methods for classification of cancer patients |
| 04/05/2012 | WO2012014190A3 Compositions and methods for prognosis of mesothelioma |
| 04/05/2012 | WO2012012742A3 Crystal structure of human alpha-n-acetylglucosaminidase |
| 04/05/2012 | WO2012009667A3 Targeted 2'-o-methylation of telomerase non-coding rna |
| 04/05/2012 | WO2012009578A3 Nanopore-facilitated single molecule detection of nucleic acids |
| 04/05/2012 | WO2012006394A3 Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer |
| 04/05/2012 | WO2012006056A3 Ccr6 as a biomarker of alzheimer's disease |
| 04/05/2012 | WO2012001305A3 Novel method for continuous enzymatic regeneration of nadh and for detection of nad+ and system for implementing same |
| 04/05/2012 | WO2011158243A3 Method of diagnosing and treating cancer |
| 04/05/2012 | WO2011156795A3 Nucleic acids for multiplex organism detection and methods of use and making the same |
| 04/05/2012 | WO2011156251A3 Filtration methods and devices |
| 04/05/2012 | WO2011153501A9 Methods for improving inflammatory bowel disease diagnosis |
| 04/05/2012 | WO2011153287A3 Materials and methods for diagnosing and predicting the course of prostate cancer |
| 04/05/2012 | WO2011150115A3 Methods and apparatus for point-of-care detection of nucleic acid in a sample |
| 04/05/2012 | WO2011150075A3 Compositions and methods for detecting a neoplasia |
| 04/05/2012 | WO2011146463A3 Enhancing endotoxin detection |
| 04/05/2012 | WO2011143611A3 Karyotyping assay |
| 04/05/2012 | WO2011143478A3 Identification of nucleic acids |
| 04/05/2012 | WO2011143294A3 Systems and methods for mechanically strained cell culture |
| 04/05/2012 | WO2011140464A3 MASS SPECTROMETRY ASSAY FOR elF4E AND elF4E REGULON ACTIVITY |
| 04/05/2012 | WO2011140237A3 Process for detection of multidrug resistant tuberculosis using real-time pcr and high resolution melt analysis |
| 04/05/2012 | WO2011139920A3 Methylation-specific competitive allele-specific taqman polymerase chain reaction (cast-pcr) |
| 04/05/2012 | WO2011139032A3 Primer composition for amplifying a gene region having diverse variations in a target gene |
| 04/05/2012 | WO2011133947A3 X-str multiplex system |
| 04/05/2012 | WO2011133500A3 Detection and analysis of epigenetic and genetic changes in tumor tissue |
| 04/05/2012 | WO2011126768A9 Methods and materials for detecting colorectal cancer and adenoma |
| 04/05/2012 | WO2011119915A3 Method for detecting lipogenic adenovirus |
| 04/05/2012 | WO2011116226A3 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 04/05/2012 | WO2011112634A9 Molecular indicia of cellular constituents and resolving the same by super-resolution technologies in single cells |
| 04/05/2012 | WO2011106770A3 Modified proteins and methods of making and using same |
| 04/05/2012 | WO2011012311A8 Methods and tests for screening bacterial biofilms |
| 04/05/2012 | WO2010051314A3 Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations |
| 04/05/2012 | US20120084885 Promoter, promoter control elements, and combinations, and uses thereof |
| 04/05/2012 | US20120084879 Molecular Markers Associated With Yellow Flash In Glyphosate Tolerant Soybeans |
| 04/05/2012 | US20120083590 Polypeptides having dna polymerase activity |
| 04/05/2012 | US20120083588 Neutral amino acid transporter and gene thereof |
| 04/05/2012 | US20120083529 Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| 04/05/2012 | US20120083521 Aptamers as agonists |
| 04/05/2012 | US20120083520 Ghrelin binding nucleic acids |
| 04/05/2012 | US20120083519 Methods For Diagnosing And Treating A Renal Disease In An Individual |
| 04/05/2012 | US20120083518 Cancer Treatment Targeting BRCA1-IRIS |
| 04/05/2012 | US20120083477 Proteasome inhibitors and uses thereof |
| 04/05/2012 | US20120083442 Myostatin binding agents |
| 04/05/2012 | US20120083428 Method and Device for Protein Delivery into Cells |
| 04/05/2012 | US20120083427 Kinase and phosphatase assays |
| 04/05/2012 | US20120083426 Method |
| 04/05/2012 | US20120083424 Expression of UBE2C and Other Genes Associated with Bladder Cancer Progression |
| 04/05/2012 | US20120083422 Glioblastoma Biomarkers, and Methods and Compositions |
| 04/05/2012 | US20120083421 Use of urinary ngal to diagnose and monitor hiv-associated nephropathy (hivan) |
| 04/05/2012 | US20120083420 Compositions and methods for the treatment of immune related diseases |
| 04/05/2012 | US20120083419 Method and compositions for inhibiting tumorigenesis |
| 04/05/2012 | US20120083417 Native-extension parallel sequencing |
| 04/05/2012 | US20120083011 Sensitive Methods for Detecting The Presence of Cancer |
| 04/05/2012 | US20120083010 Method for diagnosing pompe disease |
| 04/05/2012 | US20120082998 Detection of bacterial infections in subjects suffering from dyspnea |
| 04/05/2012 | US20120082997 Taggants and method of using same |
| 04/05/2012 | US20120082996 Il-21 variants |
| 04/05/2012 | US20120082995 Method for quantitative pcr amplification of deoxyribonucleic acids from a sample containing pcr inhibitors |
| 04/05/2012 | US20120082994 Expression Levels of COL4A1 and other Markers Correlating with Progression or Non-Progression of Bladder Cancer |
| 04/05/2012 | US20120082993 Detecting cancer with anti-cxcl16 and anti-cxcr6 antibodies |
| 04/05/2012 | US20120082992 Equine parasite detection |
| 04/05/2012 | US20120082991 Detection of rna-interacting regions in dna |
| 04/05/2012 | US20120082990 Recombinase Polymerase Amplification |
| 04/05/2012 | US20120082989 Uses for long polar fimbriae genes of pathogenic escherichia coli strains |
| 04/05/2012 | US20120082988 Homogeneous analyte detection |
| 04/05/2012 | US20120082987 Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof |